Coronavirus, vaccini e farmaci: la situazione al momento secondo l'ISS. News

Il gruppo Trial Clinici dell'Istituto Superiore di Sanità ha dato il via agli studi per la prevenzione e il trattamento dell'infezione da Covid-19. Gli interventi maggiormente sperimentati riguardano farmaci immunomodulatori, mentre a livello mondiale sono stati individuati 18 studi per vaccini anti-virus

CORONAVIRUS, TUTTI GLI AGGIORNAMENTI

Foto Roberto Monaldo / LaPresse
17-04-2020 Roma
Cronaca
Istituto Superiore di Sanità - Conferenza stampa su andamento epidemia Covid-19
Nella foto Giovanni Rezza

Photo Roberto Monaldo / LaPresse
17-04-2020 Rome (Italy)
Higher Institute of Health - Press conference on the progress of the Covid-19 pandemic
In the pic Giovanni Rezza

1/8 ©LaPresse

Al via da parte del gruppo Trial Clinici dell'Istituto Superiore di Sanità la mappatura e il monitoraggio degli studi clinici per la prevenzione ed il trattamento dell’infezione da coronavirus Covid-19, il cui aggiornamento è disponibile con cadenza quindicinale, già consultabile, su Epicentro. Ecco le ultime news

Sì sport pro e sci, slitta calcetto: il nuovo Dpcm

epa08473172 A laboratory employee works in a Laboratory at the Institute of Virology at the University in Marburg, Germany, 08 June 2020. The Philipps University of Marburg, the German Centre for Infection Research (DZIF), the Ludwig Maximilian University of Munich (LMU) and the University Medical Centre Hamburg-Eppendorf (UKE) are jointly researching a vaccine against the SARS-CoV-2 coronavirus. Countries around the world are taking increased measures to stem the widespread of the SARS-CoV-2 coronavirus which causes the Covid-19 disease. EPA/RONALD WITTEK

2/8 ©Ansa

Per gli studi relativi a farmaci, biologici, plasma da convalescenti o plasma iperimmune sono consultate e integrate le informazioni pubblicamente accessibili dal portale dell'Agenzia Italiana del Farmaco (AIFA) e dal portale ClinicalTrials.gov

Family Act, tutte le misure previste dal decreto

epa08473186 Stephan Becker (R), Head of the Institute of Virology at the University of Marburg and Coordinator of the 'Emerging Infectious Diseases' Division at the German Centre for Infection Research (DZIF), stand with a laboratory employee in a Laboratory at the Institute of Virology at the University in Marburg, Germany, 08 June 2020. The Philipps University of Marburg, the German Centre for Infection Research (DZIF), the Ludwig Maximilian University of Munich (LMU) and the University Medical Centre Hamburg-Eppendorf (UKE) are jointly researching a vaccine against the SARS-CoV-2 coronavirus. Countries around the world are taking increased measures to stem the widespread of the SARS-CoV-2 coronavirus which causes the Covid-19 disease. EPA/RONALD WITTEK

3/8 ©Ansa

Per gli studi sui vaccini sono consultate le informazioni pubblicamente accessibili dal portale del WHO e dal portale della McMaster University: Covid-clinical trial-traker

Conte: "Ok agli sport di contatto dal 25 giugno"

epa08449848 A researcher at work in the laboratory of the Amsterdam UMC, in Amsterdam, the Netherlands, 28 May 2020. The team of researcher Arjan Griffioen is developing a vaccine against the coronavirus. For this they use the same method as the cancer vaccine they are working on. EPA/KOEN VAN WEEL

4/8 ©Ansa

FARMACI, BIOLOGICI E PLASMA

Gli studi interventistici autorizzati in Italia dall’AIFA e/o registrati sul portale ClinicalTrials.gov al 29 maggio 2020, sono 51, di cui il 92% con uno scopo terapeutico e l’8% con uno scopo preventivo

epa08473168 A laboratory employee works in a Laboratory at the Institute of Virology at the University in Marburg, Germany, 08 June 2020. The Philipps University of Marburg, the German Centre for Infection Research (DZIF), the Ludwig Maximilian University of Munich (LMU) and the University Medical Centre Hamburg-Eppendorf (UKE) are jointly researching a vaccine against the SARS-CoV-2 coronavirus. Countries around the world are taking increased measures to stem the widespread of the SARS-CoV-2 coronavirus which causes the Covid-19 disease. EPA/RONALD WITTEK

5/8 ©Ansa

Sulla base dei dati disponibili, il numero totale dei partecipanti previsti per l'arruolamento è di 14880. Il disegno prevede la randomizzazione nel 73% degli studi

epa08449845 A researcher at work in the laboratory of the Amsterdam UMC, in Amsterdam, the Netherlands, 28 May 2020. The team of researcher Arjan Griffioen is developing a vaccine against the coronavirus. For this they use the same method as the cancer vaccine they are working on. EPA/KOEN VAN WEEL

6/8 ©Ansa

Gli interventi maggiormente sperimentati riguardano farmaci immunomodulatori (18 studi), anti-trombotici (8 studi), antimalarici (7 studi), anti-virali (5 studi). Cinque sperimentazioni riguardano plasma da convalescenti o plasma iperimmune

epa08442363 A Thai technician works at a laboratory of the Chula Vaccine Research Center in Bangkok, Thailand, 25 May 2020. A team of researchers at Chulalongkorn University, led by Professor Dr Kiat Ruxrungtham is making progress towards developing an mRNA type vaccine for the COVID-19 disease, caused by the SARS-CoV-2 coronavirus. The team in Thailand began running vaccine tests on monkeys after initial tests on mice proved to be effective. Professor Ruxrungtham said that, if these tests are successful, they will move on to human trials involving the production of 10,000 vaccine doses for 5,000 volunteers. EPA/DIEGO AZUBEL

7/8 ©Ansa

VACCINI

Nel mondo, sono stati individuati 18 studi per vaccini anti Covid-19, con 23618 partecipanti previsti per l’arruolamento

epa08442359 A Thai technician works at a laboratory of the Chula Vaccine Research Center in Bangkok, Thailand, 25 May 2020. A team of researchers at Chulalongkorn University, led by Professor Dr Kiat Ruxrungtham is making progress towards developing an mRNA type vaccine for the COVID-19 disease, caused by the SARS-CoV-2 coronavirus. The team in Thailand began running vaccine tests on monkeys after initial tests on mice proved to be effective. Professor Ruxrungtham said that, if these tests are successful, they will move on to human trials involving the production of 10,000 vaccine doses for 5,000 volunteers. EPA/DIEGO AZUBEL

8/8 ©Ansa

I primi Paesi coinvolti per numero di studi sui vaccini sono: Cina , USA, Regno Unito, Germania, Canada e Australia

Coronavirus, vaccini e farmaci: la situazione al momento secondo l'ISS. Le news

VIDEO IN EVIDENZA